Divis Laboratories surges as USFDA will be lifting import alert at Visakhapatnam unit

02 Nov 2017 Evaluate

Divis Laboratories is currently trading at Rs. 1097.70, up by 177.40 points or 19.28% from its previous closing of Rs. 920.30 on the BSE.

The scrip opened at Rs. 1012.30 and has touched a high and low of Rs. 1100.00 and Rs. 1012.30 respectively. So far 1,01,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1319.00 on 10-Nov-2016 and a 52 week low of Rs. 533.10 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 1117.00 and Rs. 851.00 respectively. The current market cap of the company is Rs. 29,317.00 crore.

The promoters holding in the company stood at 52.07%, while Institutions and Non-Institutions held 32.45% and 15.48% respectively.

The US Food and Drug Administration (USFDA) will be lifting the Import Alert 66-40 for Divis Laboratories’ Visakhapatnam unit and moving to close out the Warning letter issued to the company’s Unit-II at Visakhapatnam.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry





Divis Lab Share Price

3677.60 -39.75 (-1.07%)
19-Apr-2024 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1511.45
Dr. Reddys Lab 5923.90
Cipla 1340.95
Zydus Lifesciences 931.60
Lupin 1575.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.